People aiming to improve energy efficiency, insulin sensitivity, and metabolic flexibility
AOD 9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (GH fragment 176191), structurally modified with an N-terminal tyrosine residue to enhance stability in experimental systems
Pyridoxine at high or prolonged doses can cause sensory neuropathy
Receptors on the surface of the terminal ileum (the distal portion of the small intestine) take up the IF-B 12 complex only in the presence of calcium, which is supplied by the pancreas (6)
AOD-9604 is sometimes discussed alongside BPC-157 in joint research planning, and historically alongside GH secretagogues like Sermorelin, Ipamorelin, and GHRP-6 in fat-loss research planning
Some people feel slightly better within a few days, while others notice gradual improvement over one to two weeks